Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q4 2021 Atara Biotherapeutics Inc Earnings Call Transcript

Feb 28, 2022 / 09:30PM GMT
Release Date Price: $321.25 (-2.58%)
Operator

Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics' Fourth Quarter and Full Year 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's call is being recorded.

I'd now like to hand the call over to Mr. Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.

Eric Hyllengren
Atara Biotherapeutics, Inc. - VP of IR & Finance

Thank you, operator. Good afternoon, everyone, and welcome to Atara's Fourth Quarter and Full Year 2021 Results Conference Call. Earlier today, we issued a press release announcing our fourth quarter and full year financial results and operational progress. This press release and an updated slide deck are available in the Investors and Media section at atarabio.com.

On today's call, members from the Atara executive team will provide an update on our financial results and operational progress, and also review our upcoming key milestones and objectives. Joining me on today's call are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot